2011
DOI: 10.1007/s11845-011-0726-0
|View full text |Cite
|
Sign up to set email alerts
|

Warfarin anticoagulation: a survey of patients’ knowledge of their treatment

Abstract: Patients' understanding of warfarin treatment was poor, despite their high level of compliance.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
11
1
4

Year Published

2011
2011
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(19 citation statements)
references
References 12 publications
3
11
1
4
Order By: Relevance
“…In the study by Moran et al ., 57.7% of patients were unaware of any potential adverse effects after being educated about warfarin . The percentage of participants being aware of any adverse effects (one or more) was therefore higher in the present study.…”
Section: Discussionmentioning
confidence: 53%
See 3 more Smart Citations
“…In the study by Moran et al ., 57.7% of patients were unaware of any potential adverse effects after being educated about warfarin . The percentage of participants being aware of any adverse effects (one or more) was therefore higher in the present study.…”
Section: Discussionmentioning
confidence: 53%
“…This might be because the issue of drug interactions was not being reiterated by other health professionals, including the doctor, community pharmacist or nurse, as extensively as necessary during the 6 weeks follow‐up. Existing literature suggests drug interactions being poorly recalled by patients, with Smith et al . reporting 17% of their study population being aware of drug interactions .…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…[26] Warfarin en sık ilaç etkileşimi görülen ilaçların başını çekmesine ve her yıl yeni ruhsat alan ilaçlarla potansiyel etkileşimler artmasına rağ-men [27] OAT alan hastaların %30-75 oranı ile en az bildikleri konulardan biridir. [10,12,28,29] Biz bu ankette ilaçları ayrıntılı sorgulamadan yalnızca ilaç etkileşimi bilgisini araştırdık ve ilaç etkileşiminden haberdar hasta oranını çok düşük olarak saptadık. Diğer konularda saptamış olmamıza rağmen bu konuda bilgilendirme ile ilişki saptamadık.…”
Section: Discussionunclassified